{"transactions":[{"id":738326,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T01:05:43.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":12495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2026."}],"balance_after":12495,"derivative":{"exercise_price":26.89,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":12495},"source":{"system":"sec-edgar","filing":"0001437749-26-020717","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774926020717/rdgdoc.xml","form_type":"4"}},{"id":738325,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T01:05:43.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 11, 2026."}],"balance_after":30000,"derivative":{"exercise_price":26.89,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-020717","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774926020717/rdgdoc.xml","form_type":"4"}},{"id":740462,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-12T16:28:50.000Z","date":"2026-06-12","kind":"purchase","planned":false,"acquired":true,"shares":3810000,"price":13.12,"value":49987200.0,"ownership":{"direct":true},"balance_after":573883879,"source":{"system":"sec-edgar","filing":"0001055919-26-000007","document":"wk-form4_1781281727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000105591926000007/wk-form4_1781281727.xml","form_type":"4"}},{"id":750017,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-04T22:08:26.000Z","date":"2026-06-04","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":14.6,"value":1460000.0,"ownership":{"direct":false,"nature":"By the Mahkam Zanganeh Revocable Trust, with the Spouse of Reporting Person as Trustee"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":25824474,"source":{"system":"sec-edgar","filing":"0001055919-26-000005","document":"wk-form4_1780610903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000105591926000005/wk-form4_1780610903.xml","form_type":"4"}},{"id":777619,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2026-05-15T23:25:26.000Z","date":"2026-05-11","kind":"purchase","planned":false,"acquired":true,"shares":660233,"price":19.69,"value":12999987.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported herein were acquired through the Company's at-the-market equity offering program established pursuant to that certain Equity Distribution Agreement, dated February 19, 2026, by and between the Company and TD Securities (USA) LLC, as sales agent. The shares were purchased during an open trading window under the Company's Insider Trading Policy and in accordance with applicable securities laws."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares reported herein were acquired through the Company's at-the-market equity offering program at the prevailing market bid price or better at the time of sale."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes approximately 700 shares inadvertently not reported in the Company's Schedule 14A filed on May 11, 2026."}],"balance_after":48370047,"source":{"system":"sec-edgar","filing":"0001437749-26-017478","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774926017478/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-05-11"}},{"id":785328,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2026-05-11T22:52:09.000Z","date":"2026-05-11","kind":"purchase","planned":false,"acquired":true,"shares":660233,"price":19.69,"value":12999987.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported herein were acquired through the Company's at-the-market equity offering program established pursuant to that certain Equity Distribution Agreement, dated February 19, 2026, by and between the Company and TD Securities (USA) LLC, as sales agent. The shares were purchased during an open trading window under the Company's Insider Trading Policy and in accordance with applicable securities laws."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares reported herein were acquired through the Company's at-the-market equity offering program at the prevailing market bid price or better at the time of sale."}],"balance_after":48211433,"source":{"system":"sec-edgar","filing":"0001437749-26-016188","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774926016188/rdgdoc.xml","form_type":"4"}},{"id":947733,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T00:50:20.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":11232,"price":8.76,"value":98392.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $98,400."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":11232,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":11232},"source":{"system":"sec-edgar","filing":"0001055919-26-000003","document":"wk-form4_1767747017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000105591926000003/wk-form4_1767747017.xml","form_type":"4"}},{"id":1014317,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-23T20:08:30.000Z","date":"2025-10-21","kind":"purchase","planned":false,"acquired":true,"shares":26680,"price":18.74,"value":499983.2,"ownership":{"direct":false,"nature":"Immediate family member of Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":76680,"source":{"system":"sec-edgar","filing":"0001055919-25-000003","document":"wk-form4_1761250107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000105591925000003/wk-form4_1761250107.xml","form_type":"4"}},{"id":1014316,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-23T20:08:30.000Z","date":"2025-10-21","kind":"grant","planned":false,"acquired":true,"shares":266808,"price":18.74,"value":4999981.92,"ownership":{"direct":false,"nature":"By the Mahkam Zanganeh Revocable Trust, with the Spouse of Reporting Person as Trustee"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":25724474,"source":{"system":"sec-edgar","filing":"0001055919-25-000003","document":"wk-form4_1761250107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000105591925000003/wk-form4_1761250107.xml","form_type":"4"}},{"id":1014315,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-23T20:08:30.000Z","date":"2025-10-21","kind":"grant","planned":false,"acquired":true,"shares":13980789,"price":18.74,"value":261999985.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025."}],"balance_after":570073879,"source":{"system":"sec-edgar","filing":"0001055919-25-000003","document":"wk-form4_1761250107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000105591925000003/wk-form4_1761250107.xml","form_type":"4"}},{"id":1041917,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-09-13T00:14:18.000Z","date":"2024-09-12","kind":"purchase","planned":false,"acquired":true,"shares":145140,"price":14.41,"value":2091467.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Volume-weighted average price. The price per share actually paid by the Reporting Person ranged from $13.90 to $14.75 per share."}],"balance_after":47709140,"source":{"system":"sec-edgar","filing":"0001437749-25-028988","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774925028988/rdgdoc.xml","form_type":"4"}},{"id":1041916,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-09-13T00:14:18.000Z","date":"2024-09-11","kind":"purchase","planned":false,"acquired":true,"shares":12800,"price":14.77,"value":189056.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Volume-weighted average price. The price per share actually paid by the Reporting Person ranged from $14.57 to $14.79 per share."}],"balance_after":47564000,"source":{"system":"sec-edgar","filing":"0001437749-25-028988","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774925028988/rdgdoc.xml","form_type":"4"}},{"id":1041915,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-09-13T00:14:18.000Z","date":"2025-09-10","kind":"purchase","planned":false,"acquired":true,"shares":34659,"price":14.66,"value":508100.94,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price. The price per share actually paid by the Reporting Person ranged from $14.51 to $14.81 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":47551200,"source":{"system":"sec-edgar","filing":"0001437749-25-028988","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774925028988/rdgdoc.xml","form_type":"4"}},{"id":1043204,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-11T23:32:04.000Z","date":"2025-09-11","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":18.07,"value":90350.0,"ownership":{"direct":true},"balance_after":556093090,"source":{"system":"sec-edgar","filing":"0001599298-25-000142","document":"wk-form4_1757633519.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000142/wk-form4_1757633519.xml","form_type":"4"}},{"id":1043203,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-11T23:32:04.000Z","date":"2025-09-10","kind":"purchase","planned":false,"acquired":true,"shares":333394,"price":17.68,"value":5894405.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.49 to $17.89 per share, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":556088090,"source":{"system":"sec-edgar","filing":"0001599298-25-000142","document":"wk-form4_1757633519.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000142/wk-form4_1757633519.xml","form_type":"4"}},{"id":1062732,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2025-08-20T01:17:31.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":20792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2025."}],"balance_after":20792,"derivative":{"exercise_price":16.16,"expiration_date":"2035-08-15","underlying":"Common Stock","underlying_shares":20792},"source":{"system":"sec-edgar","filing":"0001437749-25-027394","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774925027394/rdgdoc.xml","form_type":"4"}},{"id":1062731,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2025-08-20T01:17:31.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 15, 2025."}],"balance_after":30000,"derivative":{"exercise_price":16.16,"expiration_date":"2035-08-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-027394","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774925027394/rdgdoc.xml","form_type":"4"}},{"id":1128156,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-02T20:55:56.000Z","date":"2025-05-30","kind":"exercise","planned":false,"acquired":false,"shares":74545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 30, 2025, the Reporting Person exercised an option to purchase 74,545 shares of the Issuer's common stock at an exercise price of $2.64 per share. The Reporting Person did not sell the underlying shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2024. The shares underlying the option vested in four equal quarterly installments on March 31, June 30, September 30 and December 31, 2024."}],"balance_after":0,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":74545},"source":{"system":"sec-edgar","filing":"0001599298-25-000106","document":"wk-form4_1748897749.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000106/wk-form4_1748897749.xml","form_type":"4"}},{"id":1128155,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-02T20:55:56.000Z","date":"2025-05-30","kind":"exercise","planned":false,"acquired":true,"shares":74545,"price":2.64,"value":196798.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 30, 2025, the Reporting Person exercised an option to purchase 74,545 shares of the Issuer's common stock at an exercise price of $2.64 per share. The Reporting Person did not sell the underlying shares."}],"balance_after":555754696,"source":{"system":"sec-edgar","filing":"0001599298-25-000106","document":"wk-form4_1748897749.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000106/wk-form4_1748897749.xml","form_type":"4"}},{"id":1162746,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-01T22:09:55.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":9590558,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":9590558,"derivative":{"exercise_price":1.68,"expiration_date":"2033-10-13","underlying":"Common Stock","underlying_shares":9590558},"source":{"system":"sec-edgar","filing":"0001599298-25-000093","document":"wk-form4_1746137388.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000093/wk-form4_1746137388.xml","form_type":"4"}},{"id":1162745,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-01T22:09:55.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":400000,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":400000,"derivative":{"exercise_price":1.29,"expiration_date":"2032-09-09","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001599298-25-000093","document":"wk-form4_1746137388.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000093/wk-form4_1746137388.xml","form_type":"4"}},{"id":1162744,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-01T22:09:55.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":1040000,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":1040000,"derivative":{"exercise_price":1.06,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":1040000},"source":{"system":"sec-edgar","filing":"0001599298-25-000093","document":"wk-form4_1746137388.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000093/wk-form4_1746137388.xml","form_type":"4"}},{"id":1174885,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2025-04-09T21:12:06.000Z","date":"2025-04-08","kind":"other","planned":false,"acquired":true,"shares":3985055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 8, 2025, the Reporting Person exercised warrants to purchase an aggregate of 3,985,055 shares of the Issuer's common stock at an exercise price of $1.58 per share."}],"balance_after":0,"derivative":{"exercise_price":1.58,"exercise_date":"2020-06-24","expiration_date":"2029-12-24","underlying":"Common Stock","underlying_shares":3985055},"source":{"system":"sec-edgar","filing":"0001599298-25-000058","document":"wk-form4_1744233117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000058/wk-form4_1744233117.xml","form_type":"4"}},{"id":1174884,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-09T21:12:06.000Z","date":"2025-04-08","kind":"other","planned":false,"acquired":true,"shares":3985055,"price":1.58,"value":6296386.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 8, 2025, the Reporting Person exercised warrants to purchase an aggregate of 3,985,055 shares of the Issuer's common stock at an exercise price of $1.58 per share."}],"balance_after":555680151,"source":{"system":"sec-edgar","filing":"0001599298-25-000058","document":"wk-form4_1744233117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000058/wk-form4_1744233117.xml","form_type":"4"}},{"id":1311553,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T00:49:10.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":10724,"price":9.18,"value":98446.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the Director Retainer Option Election Plan of issuer in lieu of retainer fees of $98,400."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":10724,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":10724},"source":{"system":"sec-edgar","filing":"0001599298-25-000030","document":"wk-form4_1736210941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000030/wk-form4_1736210941.xml","form_type":"4"}},{"id":1327227,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2024-12-19T02:36:26.000Z","date":"2024-12-18","kind":"other","planned":false,"acquired":false,"shares":24656,"ownership":{"direct":false,"nature":"Affiliated Company 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person acquired the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares and Warrants held by Blazon Corporation, of which the Reporting Person is the sole shareholder."}],"balance_after":0,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":24656},"source":{"system":"sec-edgar","filing":"0000950170-24-138177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000095017024138177/ownership.xml","form_type":"4"}},{"id":1327226,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2024-12-19T02:36:26.000Z","date":"2024-12-18","kind":"other","planned":false,"acquired":false,"shares":24656,"ownership":{"direct":false,"nature":"Affiliated Company 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person acquired the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares and Warrants held by Blazon Corporation, of which the Reporting Person is the sole shareholder."}],"balance_after":0,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":24656},"source":{"system":"sec-edgar","filing":"0000950170-24-138177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000095017024138177/ownership.xml","form_type":"4"}},{"id":1327225,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2024-12-19T02:36:26.000Z","date":"2024-12-18","kind":"other","planned":false,"acquired":false,"shares":34510,"ownership":{"direct":false,"nature":"Affiliated Company 1"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person acquired the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares and Warrants held by Genius 24C Inc., of which the Reporting Person is the sole shareholder."}],"balance_after":0,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":34510},"source":{"system":"sec-edgar","filing":"0000950170-24-138177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000095017024138177/ownership.xml","form_type":"4"}},{"id":1327224,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2024-12-19T02:36:26.000Z","date":"2024-12-18","kind":"other","planned":false,"acquired":false,"shares":34510,"ownership":{"direct":false,"nature":"Affiliated Company 1"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person acquired the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares and Warrants held by Genius 24C Inc., of which the Reporting Person is the sole shareholder."}],"balance_after":0,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":34510},"source":{"system":"sec-edgar","filing":"0000950170-24-138177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000095017024138177/ownership.xml","form_type":"4"}},{"id":1327223,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2024-12-19T02:36:26.000Z","date":"2024-12-18","kind":"other","planned":false,"acquired":false,"shares":2593912,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person acquired the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."}],"balance_after":0,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":2593912},"source":{"system":"sec-edgar","filing":"0000950170-24-138177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000095017024138177/ownership.xml","form_type":"4"}},{"id":1327222,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2024-12-19T02:36:26.000Z","date":"2024-12-18","kind":"other","planned":false,"acquired":false,"shares":2593912,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person acquired the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."}],"balance_after":0,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":2593912},"source":{"system":"sec-edgar","filing":"0000950170-24-138177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000095017024138177/ownership.xml","form_type":"4"}},{"id":1327221,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T02:36:26.000Z","date":"2024-12-18","kind":"other","planned":false,"acquired":true,"shares":49312,"price":11,"value":542432.0,"ownership":{"direct":false,"nature":"Affiliated Company 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 18, 2024, the Reporting Person exercised warrants to purchase shares of the Issuer's common stock, at an exercise price of $11.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares and Warrants held by Blazon Corporation, of which the Reporting Person is the sole shareholder."}],"balance_after":450189,"source":{"system":"sec-edgar","filing":"0000950170-24-138177","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000095017024138177/ownership.xml","form_type":"4"}},{"id":1327220,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T02:36:26.000Z","date":"2024-12-18","kind":"other","planned":false,"acquired":true,"shares":69020,"price":11,"value":759220.0,"ownership":{"direct":false,"nature":"Affiliated Company 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 18, 2024, the Reporting Person exercised warrants to purchase shares of the Issuer's common stock, at an exercise price of $11.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares and Warrants held by Genius 24C Inc., of which the Reporting Person is the sole shareholder."}],"balance_after":630109,"source":{"system":"sec-edgar","filing":"0000950170-24-138177","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000095017024138177/ownership.xml","form_type":"4"}},{"id":1327219,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T02:36:26.000Z","date":"2024-12-18","kind":"other","planned":false,"acquired":true,"shares":5187824,"price":11,"value":57066064.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 18, 2024, the Reporting Person exercised warrants to purchase shares of the Issuer's common stock, at an exercise price of $11.00 per share."}],"balance_after":47516541,"source":{"system":"sec-edgar","filing":"0000950170-24-138177","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000095017024138177/ownership.xml","form_type":"4"}},{"id":1329512,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-12-18T01:02:46.000Z","date":"2024-12-13","kind":"purchase","planned":false,"acquired":true,"shares":55256,"price":17.18,"value":949298.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price."}],"balance_after":42328717,"source":{"system":"sec-edgar","filing":"0001437749-24-037766","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774924037766/rdgdoc.xml","form_type":"4"}},{"id":1329511,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-12-17T11:05:11.000Z","date":"2024-12-12","kind":"purchase","planned":false,"acquired":true,"shares":45404,"price":17.13,"value":777770.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price."}],"balance_after":42273461,"source":{"system":"sec-edgar","filing":"0000950170-24-136901","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000095017024136901/ownership.xml","form_type":"4"}},{"id":1332969,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-12-14T00:30:48.000Z","date":"2024-12-11","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":17.42,"value":871000.0,"ownership":{"direct":true},"balance_after":42228057,"source":{"system":"sec-edgar","filing":"0001437749-24-037509","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774924037509/rdgdoc.xml","form_type":"4"}},{"id":1332968,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-12-14T00:30:48.000Z","date":"2024-12-11","kind":"purchase","planned":false,"acquired":true,"shares":6054,"price":16.74,"value":101343.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price."}],"balance_after":42178057,"source":{"system":"sec-edgar","filing":"0001437749-24-037509","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774924037509/rdgdoc.xml","form_type":"4"}},{"id":1407968,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-13T22:25:05.000Z","date":"2024-09-11","kind":"grant","planned":false,"acquired":true,"shares":3325991,"price":22.7,"value":75499995.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of September 11, 2024, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person at a purchase price of $22.70 per share. The transaction closed on September 13, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Excludes shares underlying options and warrants held by the Reporting Person."}],"balance_after":551695096,"source":{"system":"sec-edgar","filing":"0001599298-24-000139","document":"wk-form4_1726266298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929824000139/wk-form4_1726266298.xml","form_type":"4"}},{"id":1457819,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Warrant (right to buy)","published_at":"2024-07-09T13:16:24.000Z","date":"2024-07-03","kind":"purchase","planned":false,"acquired":true,"shares":24656,"ownership":{"direct":false,"nature":"Affiliated Company 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares and warrants are held by Blazon Corporation, of which the Reporting Person is the sole shareholder."}],"balance_after":24656,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":24656},"source":{"system":"sec-edgar","filing":"0001437749-24-022358","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774924022358/rdgdoc.xml","form_type":"4"}},{"id":1457818,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Warrant (right to buy)","published_at":"2024-07-09T13:16:24.000Z","date":"2024-07-03","kind":"purchase","planned":false,"acquired":true,"shares":24656,"ownership":{"direct":false,"nature":"Affiliated Company 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares and warrants are held by Blazon Corporation, of which the Reporting Person is the sole shareholder."}],"balance_after":24656,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":24656},"source":{"system":"sec-edgar","filing":"0001437749-24-022358","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774924022358/rdgdoc.xml","form_type":"4"}},{"id":1457817,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Warrant (right to buy)","published_at":"2024-07-09T13:16:24.000Z","date":"2024-07-03","kind":"purchase","planned":false,"acquired":true,"shares":34510,"ownership":{"direct":false,"nature":"Affiliated Company 1"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares and warrants are held by Genius 24C Inc., of which the Reporting Person is the sole shareholder."}],"balance_after":34510,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":34510},"source":{"system":"sec-edgar","filing":"0001437749-24-022358","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774924022358/rdgdoc.xml","form_type":"4"}},{"id":1457816,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Warrant (right to buy)","published_at":"2024-07-09T13:16:24.000Z","date":"2024-07-03","kind":"purchase","planned":false,"acquired":true,"shares":34510,"ownership":{"direct":false,"nature":"Affiliated Company 1"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares and warrants are held by Genius 24C Inc., of which the Reporting Person is the sole shareholder."}],"balance_after":34510,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":34510},"source":{"system":"sec-edgar","filing":"0001437749-24-022358","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774924022358/rdgdoc.xml","form_type":"4"}},{"id":1457815,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Warrant (right to buy)","published_at":"2024-07-09T13:16:24.000Z","date":"2024-07-03","kind":"purchase","planned":false,"acquired":true,"shares":2593912,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."}],"balance_after":2593912,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":2593912},"source":{"system":"sec-edgar","filing":"0001437749-24-022358","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774924022358/rdgdoc.xml","form_type":"4"}},{"id":1457814,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Warrant (right to buy)","published_at":"2024-07-09T13:16:24.000Z","date":"2024-07-03","kind":"purchase","planned":false,"acquired":true,"shares":2593912,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."}],"balance_after":2593912,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":2593912},"source":{"system":"sec-edgar","filing":"0001437749-24-022358","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774924022358/rdgdoc.xml","form_type":"4"}},{"id":1457813,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-07-09T13:16:24.000Z","date":"2024-07-03","kind":"other","planned":false,"acquired":true,"shares":49312,"ownership":{"direct":false,"nature":"Affiliated Company 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares and warrants are held by Blazon Corporation, of which the Reporting Person is the sole shareholder."}],"balance_after":400877,"source":{"system":"sec-edgar","filing":"0001437749-24-022358","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774924022358/rdgdoc.xml","form_type":"4"}},{"id":1457812,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-07-09T13:16:24.000Z","date":"2024-07-03","kind":"other","planned":false,"acquired":true,"shares":69020,"ownership":{"direct":false,"nature":"Affiliated Company 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares and warrants are held by Genius 24C Inc., of which the Reporting Person is the sole shareholder."}],"balance_after":561089,"source":{"system":"sec-edgar","filing":"0001437749-24-022358","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774924022358/rdgdoc.xml","form_type":"4"}},{"id":1457811,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-07-09T13:16:24.000Z","date":"2024-07-03","kind":"other","planned":false,"acquired":true,"shares":5187824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."}],"balance_after":42172003,"source":{"system":"sec-edgar","filing":"0001437749-24-022358","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774924022358/rdgdoc.xml","form_type":"4"}},{"id":1471083,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2024-06-24T23:33:58.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":16247,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2024."}],"balance_after":16247,"derivative":{"exercise_price":14.55,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":16247},"source":{"system":"sec-edgar","filing":"0001437749-24-021125","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774924021125/rdgdoc.xml","form_type":"4"}},{"id":1471082,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2024-06-24T23:33:58.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 6, 2024."}],"balance_after":20000,"derivative":{"exercise_price":14.55,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-24-021125","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774924021125/rdgdoc.xml","form_type":"4"}},{"id":1688718,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T21:16:45.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":74545,"price":1.32,"value":98399.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $98,400."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":74545,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":74545},"source":{"system":"sec-edgar","filing":"0001599298-24-000006","document":"wk-form4_1704402965.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929824000006/wk-form4_1704402965.xml","form_type":"4"}},{"id":1711296,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-15T00:37:55.000Z","date":"2023-12-12","kind":"purchase","planned":false,"acquired":true,"shares":17999,"price":9.15,"value":164690.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price."}],"balance_after":36984179,"source":{"system":"sec-edgar","filing":"0001437749-23-034484","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923034484/rdgdoc.xml","form_type":"4"}},{"id":1712964,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-13T23:03:07.000Z","date":"2023-12-11","kind":"purchase","planned":false,"acquired":true,"shares":90118,"price":9.36,"value":843504.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price."}],"balance_after":36966180,"source":{"system":"sec-edgar","filing":"0001437749-23-034371","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923034371/rdgdoc.xml","form_type":"4"}},{"id":1715000,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-13T00:28:10.000Z","date":"2023-12-08","kind":"purchase","planned":false,"acquired":true,"shares":116656,"price":9.54,"value":1112898.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price."}],"balance_after":36876062,"source":{"system":"sec-edgar","filing":"0001437749-23-034250","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923034250/rdgdoc.xml","form_type":"4"}},{"id":1716698,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-12T01:13:16.000Z","date":"2023-12-07","kind":"purchase","planned":false,"acquired":true,"shares":74852,"price":9.19,"value":687889.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price."}],"balance_after":36759406,"source":{"system":"sec-edgar","filing":"0001437749-23-034104","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923034104/rdgdoc.xml","form_type":"4"}},{"id":1718205,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2023-12-09T00:38:33.000Z","date":"2023-12-06","kind":"exercise","planned":false,"acquired":false,"shares":9933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vests on a quarterly basis following the Company's 2023 Annual Stockholder Meeting."}],"balance_after":0,"derivative":{"exercise_price":5.95,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":9933},"source":{"system":"sec-edgar","filing":"0001437749-23-034041","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923034041/rdgdoc.xml","form_type":"4"}},{"id":1718204,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-09T00:38:33.000Z","date":"2023-12-06","kind":"purchase","planned":false,"acquired":true,"shares":82813,"price":9.06,"value":750285.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price."}],"balance_after":36684554,"source":{"system":"sec-edgar","filing":"0001437749-23-034041","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923034041/rdgdoc.xml","form_type":"4"}},{"id":1718203,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-09T00:38:33.000Z","date":"2023-12-06","kind":"exercise","planned":false,"acquired":true,"shares":9933,"price":5.95,"value":59101.35,"ownership":{"direct":true},"balance_after":36601741,"source":{"system":"sec-edgar","filing":"0001437749-23-034041","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923034041/rdgdoc.xml","form_type":"4"}},{"id":1719325,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-08T01:34:43.000Z","date":"2023-12-05","kind":"purchase","planned":false,"acquired":true,"shares":66021,"price":9.34,"value":616636.14,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Blazon Corporation, of which the Reporting Person is the majority shareholder."}],"balance_after":351565,"source":{"system":"sec-edgar","filing":"0001437749-23-033920","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923033920/rdgdoc.xml","form_type":"4"}},{"id":1720385,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2023-12-07T00:54:50.000Z","date":"2023-12-04","kind":"exercise","planned":false,"acquired":false,"shares":20347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vested on a quarterly basis following the Company's 2020 Annual Stockholder Meeting."}],"balance_after":0,"derivative":{"exercise_price":10.66,"expiration_date":"2030-05-18","underlying":"Common Stock","underlying_shares":20347},"source":{"system":"sec-edgar","filing":"0001437749-23-033803","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923033803/rdgdoc.xml","form_type":"4"}},{"id":1720384,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2023-12-07T00:54:50.000Z","date":"2023-12-04","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vested on a monthly basis following the Company's 2020 Annual Stockholder Meeting."}],"balance_after":0,"derivative":{"exercise_price":10.66,"expiration_date":"2030-05-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-23-033803","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923033803/rdgdoc.xml","form_type":"4"}},{"id":1720383,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-07T00:54:50.000Z","date":"2023-12-04","kind":"purchase","planned":false,"acquired":true,"shares":27000,"price":10.38,"value":280260.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Blazon Corporation, of which the Reporting Person is the majority shareholder."}],"balance_after":285544,"source":{"system":"sec-edgar","filing":"0001437749-23-033803","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923033803/rdgdoc.xml","form_type":"4"}},{"id":1720382,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-07T00:54:50.000Z","date":"2023-12-04","kind":"exercise","planned":false,"acquired":true,"shares":20347,"price":10.66,"value":216899.02,"ownership":{"direct":true},"balance_after":36591808,"source":{"system":"sec-edgar","filing":"0001437749-23-033803","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923033803/rdgdoc.xml","form_type":"4"}},{"id":1720381,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-07T00:54:50.000Z","date":"2023-12-04","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":10.66,"value":213200.0,"ownership":{"direct":true},"balance_after":36571461,"source":{"system":"sec-edgar","filing":"0001437749-23-033803","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923033803/rdgdoc.xml","form_type":"4"}},{"id":1722437,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-06T01:31:12.000Z","date":"2023-12-01","kind":"purchase","planned":false,"acquired":true,"shares":45600,"price":9.07,"value":413592.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Blazon Corporation, of which the Reporting Person is the majority shareholder."}],"balance_after":258544,"source":{"system":"sec-edgar","filing":"0001437749-23-033705","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923033705/rdgdoc.xml","form_type":"4"}},{"id":1724292,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-05T00:37:05.000Z","date":"2023-11-30","kind":"purchase","planned":false,"acquired":true,"shares":152944,"price":9.06,"value":1385672.64,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Blazon Corporation, of which the Reporting Person is the majority shareholder."}],"balance_after":212944,"source":{"system":"sec-edgar","filing":"0001437749-23-033556","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923033556/rdgdoc.xml","form_type":"4"}},{"id":1725822,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2023-12-02T00:36:48.000Z","date":"2023-11-29","kind":"exercise","planned":false,"acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vests on a monthly basis following the Company's last Annual Stockholder Meeting."}],"balance_after":10000,"derivative":{"exercise_price":5.95,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001437749-23-033434","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923033434/rdgdoc.xml","form_type":"4"}},{"id":1725821,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-02T00:36:48.000Z","date":"2023-11-29","kind":"purchase","planned":false,"acquired":true,"shares":60000,"price":9.21,"value":552600.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Blazon Corporation, of which the Reporting Person is the majority shareholder."}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001437749-23-033434","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923033434/rdgdoc.xml","form_type":"4"}},{"id":1725820,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-02T00:36:48.000Z","date":"2023-11-29","kind":"purchase","planned":false,"acquired":true,"shares":158600,"price":9.44,"value":1497184.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price."}],"balance_after":36551461,"source":{"system":"sec-edgar","filing":"0001437749-23-033434","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923033434/rdgdoc.xml","form_type":"4"}},{"id":1725819,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-02T00:36:48.000Z","date":"2023-11-29","kind":"exercise","planned":false,"acquired":true,"shares":1667,"price":5.95,"value":9918.65,"ownership":{"direct":true},"balance_after":36392861,"source":{"system":"sec-edgar","filing":"0001437749-23-033434","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923033434/rdgdoc.xml","form_type":"4"}},{"id":1727107,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-01T00:25:50.000Z","date":"2023-11-28","kind":"purchase","planned":false,"acquired":true,"shares":124397,"price":8.98,"value":1117085.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price."}],"balance_after":36391194,"source":{"system":"sec-edgar","filing":"0001437749-23-033276","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923033276/rdgdoc.xml","form_type":"4"}},{"id":1735026,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-11-21T01:56:32.000Z","date":"2023-11-17","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":6.11,"value":61100.0,"ownership":{"direct":true},"balance_after":36266797,"source":{"system":"sec-edgar","filing":"0001437749-23-032670","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923032670/rdgdoc.xml","form_type":"4"}},{"id":1735025,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-11-21T01:56:32.000Z","date":"2023-11-17","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":6.09,"value":60900.0,"ownership":{"direct":true},"balance_after":36256797,"source":{"system":"sec-edgar","filing":"0001437749-23-032670","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923032670/rdgdoc.xml","form_type":"4"}},{"id":1735024,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-11-21T01:56:32.000Z","date":"2023-11-17","kind":"purchase","planned":false,"acquired":true,"shares":241,"price":6.1,"value":1470.1,"ownership":{"direct":true},"balance_after":36246797,"source":{"system":"sec-edgar","filing":"0001437749-23-032670","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923032670/rdgdoc.xml","form_type":"4"}},{"id":1745994,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2023-11-09T23:32:32.000Z","date":"2023-11-07","kind":"exercise","planned":false,"acquired":false,"shares":9932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vests on a quarterly basis following the Company's last Annual Stockholder Meeting."}],"balance_after":29799,"derivative":{"exercise_price":5.95,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":9932},"source":{"system":"sec-edgar","filing":"0001437749-23-031322","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923031322/rdgdoc.xml","form_type":"4"}},{"id":1745993,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2023-11-09T23:32:32.000Z","date":"2023-11-07","kind":"exercise","planned":false,"acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vests on a monthly basis following the Company's last Annual Stockholder Meeting."}],"balance_after":11667,"derivative":{"exercise_price":5.95,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001437749-23-031322","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923031322/rdgdoc.xml","form_type":"4"}},{"id":1745992,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-11-09T23:32:32.000Z","date":"2023-11-07","kind":"exercise","planned":false,"acquired":true,"shares":9932,"price":5.95,"value":59095.4,"ownership":{"direct":true},"balance_after":36246556,"source":{"system":"sec-edgar","filing":"0001437749-23-031322","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923031322/rdgdoc.xml","form_type":"4"}},{"id":1745991,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-11-09T23:32:32.000Z","date":"2023-11-07","kind":"exercise","planned":false,"acquired":true,"shares":3333,"price":5.95,"value":19831.35,"ownership":{"direct":true},"balance_after":36236624,"source":{"system":"sec-edgar","filing":"0001437749-23-031322","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923031322/rdgdoc.xml","form_type":"4"}},{"id":1795522,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2023-08-29T00:08:47.000Z","date":"2023-08-25","kind":"exercise","planned":false,"acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vests on a monthly basis following the Company's last Annual Stockholder Meeting."}],"balance_after":15000,"derivative":{"exercise_price":5.95,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001437749-23-024790","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923024790/rdgdoc.xml","form_type":"4"}},{"id":1795521,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-29T00:08:47.000Z","date":"2023-08-25","kind":"exercise","planned":false,"acquired":true,"shares":1667,"price":5.95,"value":9918.65,"ownership":{"direct":true},"balance_after":36233291,"source":{"system":"sec-edgar","filing":"0001437749-23-024790","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923024790/rdgdoc.xml","form_type":"4"}},{"id":1822346,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2023-07-27T13:09:51.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vests on a monthly basis following the Company's last Annual Stockholder Meeting."}],"balance_after":16667,"derivative":{"exercise_price":5.95,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001437749-23-020812","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923020812/rdgdoc.xml","form_type":"4"}},{"id":1822345,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-07-27T13:09:51.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":true,"shares":1667,"price":5.95,"value":9918.65,"ownership":{"direct":true},"balance_after":36231624,"source":{"system":"sec-edgar","filing":"0001437749-23-020812","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923020812/rdgdoc.xml","form_type":"4"}},{"id":1833146,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2023-07-07T22:26:49.000Z","date":"2023-07-07","kind":"exercise","planned":false,"acquired":false,"shares":1666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vests on a monthly basis following the Company's last Annual Stockholder Meeting."}],"balance_after":18334,"derivative":{"exercise_price":5.95,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":1666},"source":{"system":"sec-edgar","filing":"0001437749-23-019620","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923019620/rdgdoc.xml","form_type":"4"}},{"id":1833145,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2023-07-07T22:26:49.000Z","date":"2023-07-07","kind":"exercise","planned":false,"acquired":false,"shares":65467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the shares subject to the option are fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":2.14,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":65467},"source":{"system":"sec-edgar","filing":"0001437749-23-019620","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923019620/rdgdoc.xml","form_type":"4"}},{"id":1833144,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2023-07-07T22:26:49.000Z","date":"2023-07-05","kind":"exercise","planned":false,"acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the shares subject to the option are fully vested and exercisable as of the date hereof."}],"balance_after":65467,"derivative":{"exercise_price":2.14,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001437749-23-019620","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923019620/rdgdoc.xml","form_type":"4"}},{"id":1833143,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-07-07T22:26:49.000Z","date":"2023-07-07","kind":"exercise","planned":false,"acquired":true,"shares":1666,"price":5.95,"value":9912.7,"ownership":{"direct":true},"balance_after":36229957,"source":{"system":"sec-edgar","filing":"0001437749-23-019620","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923019620/rdgdoc.xml","form_type":"4"}},{"id":1833142,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-07-07T22:26:49.000Z","date":"2023-07-07","kind":"exercise","planned":false,"acquired":true,"shares":65467,"price":2.14,"value":140099.38,"ownership":{"direct":true},"balance_after":36228291,"source":{"system":"sec-edgar","filing":"0001437749-23-019620","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923019620/rdgdoc.xml","form_type":"4"}},{"id":1833141,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-07-07T22:26:49.000Z","date":"2023-07-05","kind":"exercise","planned":false,"acquired":true,"shares":65000,"price":2.14,"value":139100.0,"ownership":{"direct":true},"balance_after":36162824,"source":{"system":"sec-edgar","filing":"0001437749-23-019620","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923019620/rdgdoc.xml","form_type":"4"}},{"id":1853000,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2023-06-16T20:12:12.000Z","date":"2023-06-14","kind":"other","planned":false,"acquired":false,"shares":81025,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder."}],"balance_after":0,"derivative":{"exercise_price":2.05,"exercise_date":"2022-06-09","expiration_date":"2027-06-09","underlying":"Common Stock","underlying_shares":81025},"source":{"system":"sec-edgar","filing":"0001387131-23-007625","document":"duggan-form4_061423.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000138713123007625/duggan-form4_061423.xml","form_type":"4"}},{"id":1852999,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2023-06-16T20:12:12.000Z","date":"2023-06-14","kind":"other","planned":false,"acquired":false,"shares":5683163,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.05,"exercise_date":"2022-06-09","expiration_date":"2027-06-09","underlying":"Common Stock","underlying_shares":5683163},"source":{"system":"sec-edgar","filing":"0001387131-23-007625","document":"duggan-form4_061423.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000138713123007625/duggan-form4_061423.xml","form_type":"4"}},{"id":1852998,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:12:12.000Z","date":"2023-06-14","kind":"other","planned":false,"acquired":true,"shares":81025,"price":2.05,"value":166101.25,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder."}],"balance_after":492069,"source":{"system":"sec-edgar","filing":"0001387131-23-007625","document":"duggan-form4_061423.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000138713123007625/duggan-form4_061423.xml","form_type":"4"}},{"id":1852997,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:12:12.000Z","date":"2023-06-14","kind":"other","planned":false,"acquired":true,"shares":5683163,"price":2.05,"value":11650484.15,"ownership":{"direct":true},"balance_after":36097824,"source":{"system":"sec-edgar","filing":"0001387131-23-007625","document":"duggan-form4_061423.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000138713123007625/duggan-form4_061423.xml","form_type":"4"}},{"id":1865532,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2023-06-07T00:47:33.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":39731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2023."}],"balance_after":39731,"derivative":{"exercise_price":5.95,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":39731},"source":{"system":"sec-edgar","filing":"0001437749-23-016820","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923016820/rdgdoc.xml","form_type":"4"}},{"id":1865531,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2023-06-07T00:47:33.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on June 25, 2023."}],"balance_after":20000,"derivative":{"exercise_price":5.95,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-23-016820","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000143774923016820/rdgdoc.xml","form_type":"4"}},{"id":1898445,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-10T21:41:30.000Z","date":"2023-05-09","kind":"purchase","planned":false,"acquired":true,"shares":10022937,"price":6.51,"value":65249319.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were acquired pursuant to the terms of that certain purchase agreement by and between the Reporting Person and the Issuer, of which consideration included the satisfaction of a loan from the Reporting Person to the Issuer."}],"balance_after":30414661,"source":{"system":"sec-edgar","filing":"0001839882-23-012510","document":"duggan-form4_050923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000183988223012510/duggan-form4_050923.xml","form_type":"4"}},{"id":1963899,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-08T21:12:01.000Z","date":"2023-03-06","kind":"purchase","acquired":true,"shares":376489880,"price":1.05,"value":395314374.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering."}],"balance_after":552354161,"source":{"system":"sec-edgar","filing":"0001839882-23-006255","document":"dugganform4_030623.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000183988223006255/dugganform4_030623.xml","form_type":"4"}},{"id":2092494,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-12-08T23:28:13.000Z","date":"2022-12-06","kind":"other","acquired":true,"shares":9346434,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"9,346,434 shares of Common Stock were issued to the Reporting Person as payment of interest in connection with a Note Purchase Agreement, dated December 6, 2022, by and among the Issuer, the Reporting Person and Dr. Maky Zanganeh. The determination of the number of shares of Common Stock to be issued to the Reporting Person was based on a per share price of $0.79."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"9,346,434 shares of Common Stock were issued to the Reporting Person as payment of interest in connection with a Note Purchase Agreement, dated December 6, 2022, by and among the Issuer, the Reporting Person and Dr. Maky Zanganeh. The determination of the number of shares of Common Stock to be issued to the Reporting Person was based on a per share price of $0.79."}],"balance_after":171879226,"source":{"system":"sec-edgar","filing":"0001387131-22-012236","document":"duggan-form4_120622.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000138713122012236/duggan-form4_120622.xml","form_type":"4"}},{"id":2180033,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-18T20:38:34.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":94849203,"price":0.97,"value":92003726.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering."}],"balance_after":162532792,"source":{"system":"sec-edgar","filing":"0001387131-22-008888","document":"duggan-form4_081622.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000138713122008888/duggan-form4_081622.xml","form_type":"4"}},{"id":2236518,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2022-06-10T23:00:56.000Z","date":"2022-06-09","kind":"purchase","acquired":true,"shares":81025,"ownership":{"direct":false,"nature":"footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder."}],"balance_after":81025,"derivative":{"exercise_price":2.05,"exercise_date":"2022-06-09","expiration_date":"2027-06-09","underlying":"Common Stock","underlying_shares":81025},"source":{"system":"sec-edgar","filing":"0001387131-22-006924","document":"duggan-form4_061022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000138713122006924/duggan-form4_061022.xml","form_type":"4"}},{"id":2236517,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2022-06-10T23:00:56.000Z","date":"2022-06-09","kind":"purchase","acquired":true,"shares":5683163,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC."}],"balance_after":5683163,"derivative":{"exercise_price":2.05,"exercise_date":"2022-06-09","expiration_date":"2027-06-09","underlying":"Common Stock","underlying_shares":5683163},"source":{"system":"sec-edgar","filing":"0001387131-22-006924","document":"duggan-form4_061022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000138713122006924/duggan-form4_061022.xml","form_type":"4"}}],"next_cursor":"2022-06-10T23:00:56.000000Z,2236517"}